ロード中...
Recent advances of highly selective CDK4/6 inhibitors in breast cancer
Uncontrolled cell division is the hallmark of cancers. Full understanding of cell cycle regulation would contribute to promising cancer therapies. In particular, cyclin-dependent kinases 4/6 (CDK4/6), which are pivotal drivers of cell proliferation by combination with cyclin D, draw more and more at...
保存先:
| 出版年: | J Hematol Oncol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5404666/ https://ncbi.nlm.nih.gov/pubmed/28438180 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-017-0467-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|